Non-Current Assets
Long-term marketable securities
Pfizer Long-term marketable securities decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Long-term marketable securities shows a downward trend with a -62.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase indicates a long-term capital preservation strategy, while a decrease suggests the liquidation of long-term investments to fund operations or debt repayment.
Detailed definition
This represents long-term investments in debt securities that the company intends to hold for more than one year. These...
Peer comparison
Used by mature companies with strong cash flows to manage long-term liquidity and investment returns.
Metric ID:
non_current_assets_available_for_sale_securities_debt_se_908f76Historical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $63.00M | $434.00M | $521.00M | $569.00M | $379.00M | $358.00M | $352.00M | $333.00M | $254.00M | $211.00M | $150.00M | $137.00M | $69.00M | $6.00M | $0.00 | $1.00M | $1.00M | $1.00M | $0.00 |
| QoQ Change | — | +588.9% | +20.0% | +9.2% | -33.4% | -5.5% | -1.7% | -5.4% | -23.7% | -16.9% | -28.9% | -8.7% | -49.6% | -91.3% | -100.0% | — | +0.0% | +0.0% | -100.0% |
| YoY Change | — | — | — | — | +501.6% | -17.5% | -32.4% | -41.5% | -33.0% | -41.1% | -57.4% | -58.9% | -72.8% | -97.2% | -100.0% | -98.6% | -83.3% | — | — |
Range$0.00 – $569.00M
CAGR-100.0%
Avg YoY Growth-17.8%
Median YoY Growth-57.4%
Long-term marketable securities at Other Companies
Frequently Asked Questions
- What is Pfizer's long-term marketable securities?
- Pfizer (PFE) reported long-term marketable securities of $0.00 in Q1 2026.
- What is the long-term trend for Pfizer's long-term marketable securities?
- Over 5 years (2020 to 2025), Pfizer's long-term marketable securities has grown at a -62.1% compound annual growth rate (CAGR), from $128.00M to $1.00M.
- What does long-term marketable securities mean?
- Long-term investments in debt securities held for interest income.